La-Up Aroon, Wongrith Paleeratana, Chaichan Wiraphon, Aramrattana Apinun, Saengow Udomsak
School of Public Health, Walailak University, Thai Buri, Tha Sala, Nakhon Si Thammarat, 80160, Thailand.
Center of Excellence in Data Science for Health Study, Walailak University, Thai Buri, Tha Sala, Nakhon Si Thammarat, 80160, Thailand.
Heliyon. 2022 May 18;8(5):e09468. doi: 10.1016/j.heliyon.2022.e09468. eCollection 2022 May.
There are evidence about effects of kratom () use on parameters related to metabolic syndrome (MetS). The present study aimed to determine the association between kratom use and MetS.
This study is a cross-sectional study of 581 subjects (kratom users and non-users) aged 18 and over from the Nam Phu sub-district, Surat Thani province, Thailand. The association was determined using multivariate logistic regression.
MetS prevalence in kratom users and non-users was 11.9% (95% CI, 8.4-16.3%) and 21.6 % (95% CI, 17.1-26.8%), respectively. The use of kratom was associated with the lower odds of MetS (adjusted OR, 0.56; 95% CI, 0.33-0.96). Kratom use were associated with smaller waist circumference, lower triglycerides, and higher high-density lipoprotein.
The current study demonstrated a potential protective effect of kratom use against MetS.
有证据表明使用 kratom（）对与代谢综合征（MetS）相关的参数有影响。本研究旨在确定使用 kratom 与 MetS 之间的关联。
本研究是一项横断面研究，对来自泰国素叻他尼府喃富区的581名18岁及以上的受试者（kratom使用者和非使用者）进行了研究。使用多因素逻辑回归确定关联。
kratom使用者和非使用者的MetS患病率分别为11.9%（95%CI，8.4 - 16.3%）和21.6%（95%CI，17.1 - 26.8%）。使用kratom与较低的MetS患病几率相关（调整后的OR，0.56；95%CI，0.33 - 0.96）。使用kratom与较小的腰围、较低的甘油三酯和较高的高密度脂蛋白相关。
当前研究表明使用kratom对MetS有潜在的保护作用。
